Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2011 5
2012 6
2013 9
2014 7
2015 4
2016 1
2017 4
2018 3
2019 5
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

41 results
Results by year
Filters applied: . Clear all
Page 1
Identifying the correlates of membership in HIV-serodiscordant partnerships in New York City.
Braunstein SL, Udeagu CC, Bocour A, Renaud T, Shepard CW. Braunstein SL, et al. Sex Transm Dis. 2013 Oct;40(10):784-91. doi: 10.1097/OLQ.0000000000000007. Sex Transm Dis. 2013. PMID: 24275728
BACKGROUND: Identification and characterization of patients in HIV-serodiscordant partnerships can inform strategies to improve HIV prevention efforts for this group. ...Index patients claimed more partners than they named; for example, index patien
BACKGROUND: Identification and characterization of patients in HIV-serodiscordant partnerships can inform strategies to improve HIV p …
Characteristics of a cohort of high-risk men who have sex with men on pre-exposure prophylaxis reporting transgender sexual partners.
Hassan A, Wertheim JO, Blumenthal JS, Ellorin E, Dube MP, Corado K, Moore DJ, Morris SR. Hassan A, et al. Medicine (Baltimore). 2019 Dec;98(50):e18232. doi: 10.1097/MD.0000000000018232. Medicine (Baltimore). 2019. PMID: 31852085 Free PMC article. Clinical Trial.
MSM were more likely to report transgender partners if they were African American, had incident chlamydia, reported injection drug-using sexual partners, or received items for sex. ...Identifying this group distinct from larger cohorts of …
MSM were more likely to report transgender partners if they were African American, had incident chlamydia, reported injection
Viral suppression among HIV-infected methadone-maintained patients: The role of ongoing injection drug use and adherence to antiretroviral therapy (ART).
Shrestha R, Copenhaver MM. Shrestha R, et al. Addict Behav. 2018 Oct;85:88-93. doi: 10.1016/j.addbeh.2018.05.031. Epub 2018 May 31. Addict Behav. 2018. PMID: 29879611 Free PMC article.
Furthermore, results revealed a significant interaction effect that involved optimal ART adherence and injection of drug use on viral suppression (aOR = 2.953, p = .029). CONCLUSION: Overall, our findings highlight unaddressed HIV-related treatment
Furthermore, results revealed a significant interaction effect that involved optimal ART adherence and injection of drug
History of Incarceration Among Women with HIV: Impact on Prognosis and Mortality.
Cohen MH, Weber KM, Lancki N, Gange SJ, Plankey M, Philbin MM, Milam J, Admora AA, Kempf MC, Holman S, Cohen J, Foster A, Sosanya O, Evans CT. Cohen MH, et al. J Womens Health (Larchmt). 2019 Aug;28(8):1083-1093. doi: 10.1089/jwh.2018.7454. Epub 2019 May 17. J Womens Health (Larchmt). 2019. PMID: 31099696
Objectives: To identify factors associated with incarceration among women and examine the relationship between incarceration and human immunodeficiency virus (HIV)-related outcomes. ...Results: Overall, 1256 (38%) of women reported ever being incarcera …
Objectives: To identify factors associated with incarceration among women and examine the relationship between incarceration a …
Time Spent with HIV Viral Load > 1500 Copies/mL Among Persons Engaged in Continuity HIV Care in an Urban Clinic in the United States, 2010-2015.
Lesko CR, Lau B, Chander G, Moore RD. Lesko CR, et al. AIDS Behav. 2018 Nov;22(11):3443-3450. doi: 10.1007/s10461-018-2085-6. AIDS Behav. 2018. PMID: 29541913 Free PMC article.
We followed patients engaged in continuity care in the Johns Hopkins HIV Clinical Cohort between January 2010 and August 2015. ...Patients with lower baseline CD4 cell count, younger age, black race, history of injection drug use, or baseline ha …
We followed patients engaged in continuity care in the Johns Hopkins HIV Clinical Cohort between January 2010 and August 2015. …
Antiretroviral Therapy Use Among HIV-Infected People Who Inject Drugs-20 Cities, United States, 2009-2015.
Hoots BE, Finlayson TJ, Broz D, Paz-Bailey G; NHBS Study Group. Hoots BE, et al. J Acquir Immune Defic Syndr. 2017 Jul 1;75 Suppl 3:S392-S396. doi: 10.1097/QAI.0000000000001416. J Acquir Immune Defic Syndr. 2017. PMID: 28604444 Clinical Trial.
BACKGROUND: Approximately 16% of infections among those living with diagnosed HIV infection in the United States are attributable to injection drug use. ...CONCLUSIONS: These findings show progress in ARV treatment, although ARV coverage remains low compared …
BACKGROUND: Approximately 16% of infections among those living with diagnosed HIV infection in the United States are attributable to inje
Exploring new and existing PrEP modalities among female sex workers and women who inject drugs in a U.S. city.
Footer KHA, Lim S, Rael CT, Greene GJ, Carballa-Diéguez A, Giguere R, Martinez M, Bockting W, D'Aquila R, Sherman SG. Footer KHA, et al. AIDS Care. 2019 Oct;31(10):1207-1213. doi: 10.1080/09540121.2019.1587352. Epub 2019 Mar 1. AIDS Care. 2019. PMID: 30822101
To address a shortage in research on Pre-Exposure Prophylaxis (PrEP) amongst women at high risk of HIV acquisition, this study explored the attitudes and preferences of female sex workers (FSW) (n = 15) and women who inject drugs (WWID) (n = 16) to existing ( …
To address a shortage in research on Pre-Exposure Prophylaxis (PrEP) amongst women at high risk of HIV acquisition, this study explor …
Sex, Race, and HIV Risk Disparities in Discontinuity of HIV Care After Antiretroviral Therapy Initiation in the United States and Canada.
Rebeiro PF, Abraham AG, Horberg MA, Althoff KN, Yehia BR, Buchacz K, Lau BM, Sterling TR, Gange SJ. Rebeiro PF, et al. AIDS Patient Care STDS. 2017 Mar;31(3):129-144. doi: 10.1089/apc.2016.0178. Epub 2017 Feb 27. AIDS Patient Care STDS. 2017. PMID: 28282246 Free PMC article.
Disruption of continuous retention in care (discontinuity) is associated with HIV disease progression. We examined sex, race, and HIV risk disparities in discontinuity after antiretroviral therapy (ART) initiation among patients in North America. ...In adjusted regr …
Disruption of continuous retention in care (discontinuity) is associated with HIV disease progression. We examined sex, race, and HIV …
Retention, Antiretroviral Therapy Use and Viral Suppression by History of Injection Drug Use Among HIV-Infected Patients in an Urban HIV Clinical Cohort.
Lesko CR, Tong W, Moore RD, Lau B. Lesko CR, et al. AIDS Behav. 2017 Apr;21(4):1016-1024. doi: 10.1007/s10461-016-1585-5. AIDS Behav. 2017. PMID: 27752872 Free PMC article.
Compared to HIV-infected persons who do not inject drugs (non-IDU), persons who inject drugs (PWID) experience disparities in linking to medical care, initiating antiretroviral therapy (ART) and achieving viral suppression. There has been little attention to …
Compared to HIV-infected persons who do not inject drugs (non-IDU), persons who inject drugs (PWID) experience disparit …
Viral suppression and HIV transmission behaviors among hospitalized patients living with HIV.
Pan Y, Metsch LR, Gooden LK, Philbin MM, Daar ES, Douaihy A, Jacobs P, Del Rio C, Rodriguez AE, Feaster DJ. Pan Y, et al. Int J STD AIDS. 2019 Aug;30(9):891-901. doi: 10.1177/0956462419846726. Epub 2019 Jun 3. Int J STD AIDS. 2019. PMID: 31159715
Persons with a detectable viral load were more likely to have sex partners who were HIV-negative or of unknown status (OR=1.72, 95% CI=1.22-2.38), report not cleaning needles after injecting drugs (OR=3.13, 95% CI=1.33-7.14), and to engage in sex acts while high on …
Persons with a detectable viral load were more likely to have sex partners who were HIV-negative or of unknown status (OR=1.72, 95% C …
41 results
Jump to page
Feedback